http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2014006538-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5eec6a79b5be5971a03fe7cb5dab580 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498 |
| filingDate | 2014-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b1d9db951648ad6134a6442d6e94f7b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5547de3e67d3abc441c96c7631f788c |
| publicationDate | 2015-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | MX-2014006538-A |
| titleOfInvention | NEW AMEBICIDE COMPOUNDS DERIVED FROM ETHYL AND METHYL QUINOXALINA-7-CARBOXYLATE 1,4-DI-N-OXIDE. |
| abstract | This invention refers to quinoxaline 1,4-di-N-oxide derivatives functionalized in position 7 with groups derived from ethyl and methyl ester with excellent selectivity on histolytic Entamoeba and low toxicity. The present invention comprises the compounds described in the following general figure, (see Formula) As well as their pharmaceutically acceptable salts and their use in medicaments for treating human and mammalian animals with amebiasis. |
| priorityDate | 2014-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.